-
Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease
-
Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
-
Quality of life and living with Parkinson’s in Ireland
-
Quality of life of Parkinson’s disease patients in a tertiary hospital in Hong Kong
-
Quantifiable changes in cortical visual processing in patients with Parkinson’s disease but no cognitive impairment
-
Quantification of postural stability in Parkinson’s disease patients utilizing mobile technology
-
Quantification of striatal dopamine transporters with [18F]PR04.MZ in patients with progressive supranuclear palsy and Parkinson’s disease
-
Quantification of tremor and rigidity during deep brain stimulation surgery for Parkison’s disease
-
Quantifying daily living transitions in patients with Parkinson’s disease using a body-fixed sensor
-
Quantifying turning behavior in Parkinson’s disease patients using mobile technology
-
Quantitative analysis of tremor in patients with cerebellar and brainstem lesions
-
Quantitative assessment of advanced therapies in Parkinson’s disease using the Parkinson kinetigraph (PKG)
-
Quantitative assessment of DBS-induced gait disorder in patients with essential tremor
-
Quantitative measurements of deficit type and severity in focal embouchure dystonia
-
Quantitative MRI measurement of regional cerebellar involvement in patients with progressive supranuclear palsy
2016 International Congress
June 19-23, 2016. Berlin, Germany.